Book Reviews | Gordon Campbell | News Flashes | Scoop Features | Scoop Video | Strange & Bizarre | Search

 


Hormone Therapy Makes Comeback--Are Cigarettes Next?

Hormone Therapy Makes Comeback--Are Cigarettes Next?

by Martha Rosenberg
November 9, 2012


Click for big version.

It has been almost ten years since a US government study found that hormone replacement therapy (HRT) did not prevent heart disease and memory loss as advertised but increased the risk of heart attacks by 29 percent and doubled the risk of dementia. Oops.

That was not all the bad news that emerged about HRT. It also increased the risk of breast cancer by 26 percent, stroke by 41 percent, doubled the risk of blood clots and increased the risk of hearing loss, gall bladder disease, urinary incontinence, asthma, the need for joint replacement, melanoma, ovarian, endometrial and lung cancers and non-Hodgkin's lymphoma, according to medical journals.

It was not exactly the fountain of youth it was billed as by hormone drug maker Wyeth (now Pfizer) in high-budget menopause awareness TV ads starring model Lauren Hutton.

In fact, HRT was such a scourge against women, in the first year that millions quit, 2003, the incidence of US breast cancer fell seven percent. It fell 15 percent among women whose tumors were fed by estrogen. Fourteen thousand women who were expected to get breast cancer didn't said news reports. And it wasn't just breast cancer women were spared: heart attack and ovarian cancer rates also fell when women quit HRT, said news reports.

The statistics must have been embarrassing to cancer researchers and public health officials. Not only was a major cause of breast cancer hidden in plain sight, the war on cancer should apparently have been a war on cancer-causing drugs!

It was even more embarrassing because the whole sequence happened before! In 1975, a Food and Drug Administration (FDA) panel found a link between Premarin (a Wyeth HRT drug) and endometrial cancer and when women quit the drug by the millions--the same thing happened. "There was a sharp downward trend in the incidence of endometrial cancer that paralleled a substantial reduction in prescriptions for replacement estrogens," reported the New England Journal of Medicine (NEJM) in 1979.

Not wanting to lose its billion dollar HRT franchise, Wyeth's medical director wrote doctors at the time that HRT still had "proven benefits" at the "the lowest maintenance dose" and that it was "simplistic indeed to attribute an apparent increase in the diagnosis of endometrial carcinoma solely to estrogen therapy."

Thirty years later, when cancer rates again dropped, Wyeth also bit back. It announced the reason women weren't seeing prevention of heart disease and memory loss from HRT was they weren't taking it soon enough. They needed to start treatment sooner. Ka-ching. The early treatment campaign was called the "timing theory."

Soon a National Institute on Aging trial and privately funded trials on "menopausal" primates, both led by Wyeth-funded investigators, were underway at major medical centers. After all, before 2002, millions of American women, perhaps the majority, had been on HRT. Wasn't there a way to get them back?

Last month the hormone revival campaign hit pay dirt. Women "who took treatments such as Pfizer Inc.'s estrogen pill Premarin within five years of menopause lowered their chance of Alzheimers by 30 percent," wrote the Washington Post about a study in the journal Neurology.

"It's really important to distinguish between studies that are able to look at early use of hormone therapy versus later use," said Pauline M. Maki, PhD on WebMD about the same study. Maki has received research support from Wyeth according to a July 2010 article in the journal Menopause. WebMD just imported a new CEO from Pfizer.

The study was funded by the National Institute on Aging (NIA) not Big Pharma. But NIA is so collegial with hormone makers, it funded the North American Menopause Society's entire 2009 annual meeting replete with Wyeth-funded doctor presenters and even Wyeth employee presenters. It also invited top Wyeth officials for a "Where Are We Now?" meeting soon after its products were linked to cancer/heart disease/blood clots/stroke/dementia.

Even if HRT did lower Alzheimer risk--would it be ethical to prescribe it in light of its other risks or even conduct trials? HRT's negative cognitive effects are so well known, a 2006 Reuters story began, "Regular exercise may prevent the mental decline associated with the long-term use of hormone replacement therapy (HRT)." And two studies in the January 13, 2009 issue of Neurology link HRT to brain shrinkage.

Hormone markers have also floated the idea that early HRT would prevent heart disease and/or cancer. But a 2011 analysis from the Million Women Study, sponsored by England's National Health Service, found women who took hormones the earliest, before or soon after the onset of menopause, were at the greatest risk of getting breast cancer.

Why does the government let--and even help--Big Pharma market HRT like it's a brand new product instead of the cause of two cancer epidemics--so far? Would anyone tell cigarette smokers to start smoking earlier?

*************

The complete story of unethical marketing of HRT to women is found in Martha Rosenberg's recent book, Born with a Junk Food Deficiency.

© Scoop Media

 
 
 
 
 
Top Scoops Headlines

 

Werewolf: Artificial Intelligence: Real Anxieties?

The movie Ex Machina feels so current there are powerful moments of recognition – despite the seemingly unlikely scenario of a walking, talking artificial intelligence (AI). Right now Google is enlisting its massive databases, drawing on the contents of every email and Internet search ever made, in the service of what has been called ‘the Manhattan Project of AI’. More>>

ALSO:

Open Source, Open Society: More Than Just Transparency

Bill Bennett: “Share and share alike” is the message parents drum into children. But once they grow up and move out into the wider world, the shutters start to come down. We’re trained to be closed. Dave Lane, president of the New Zealand Open Source Society, says that explains the discomfort people find when they first encounter the open world. More>>

ALSO:

Werewolf: Journalism, History And Forgetting

Compare that [the saturation coverage of WWI] not just with the thinly reported anniversaries last year of key battles in the New Zealand Wars, but with the coverage of the very consequential present-day efforts to remedy the damage those wars wrought, and the picture is pretty dismal. More>>

ALSO:

Werewolf: Climate Of Fear

New Zealand, promoting itself as an efficient producer, has been operating as a factory farm for overseas markets with increasing intensity ever since the introduction of refrigerated shipping in 1882. The costs to native forests and to bio-diversity have been outlandish. The discussion of impacts has been minimal... More>>

ALSO:

Greek Riddles: Gordon Campbell On The Recent Smackdown Over Greece

There had been a fortnight of fevered buildup. Yet here we are in the aftermath of the February 28 showdown between the new Syriza government in Greece and the European Union “troika” and… no-one seems entirely sure what happened. Did the asteroid miss Earth? More>>

ALSO:

Keith Rankin: Contribution Through Innovation

The economic contribution of businesses and people is often quite unrelated to their taxable incomes. EHome, as a relatively new company, may have never earned any taxable income. Its successors almost certainly will earn income and pay tax. Yet it was eHome itself who made the biggest contribution by starting the venture in the first place. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
Top Scoops
Search Scoop  
 
 
Powered by Vodafone
NZ independent news